References
- Richardson JP, Moyes DL. Adaptive immune responses to Candida albicans infection. Virulence 2015; PMID:25607781
- Costa C, Dias PJ, Sá-Correia I, Teixeira MC. MFS multidrug transporters in pathogenic fungi: do they have real clinical impact? Front Physiol 2014; 5:197; PMID:24904431.
- Bai C, Xu XL, Wang HS, Wang YM, Chan FY, Wang Y. Characterization of a hyperactive Cyr1 mutant reveals new regulatory mechanisms for cellular cAMP levels in Candida albicans. Mol Microbiol 2011; 82(4):879-93; PMID:21992526.
- Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 2011; 10(2):112-22; PMID:22158429.
- Jia XM, Tang B, Zhu LL, Liu YH, Zhao XQ, Gorjestani S, Hsu YM, Yang L, Guan JH, Xu GT, Lin X. CARD9 mediates Dectin-1-induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity. J Exp Med 2014; 211(11):2307-21; PMID:25267792.
- Losse J, Zipfel PF, Józsi M. Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity. J Immunol 2010; 184(2):912-21; PMID:20008295.
- Wang XJ, Sui X, Yan L, Wang Y, Cao YB, Jiang YY. Vaccines in the treatment of invasive candidiasis. Virulence 2015; PMID:25559739.